Hippocratic AI said it has raised $141 million in a Series B funding round. The investment is led by Kleiner Perkins, one of the most respected venture capital firms. It brings the valuation of the company to $1.64 billion, an affirmation of the increased confidence in AI-driven solutions for the healthcare industry.

Company Overview

Founders 2023. Hippocratic AI develops the biggest language models especially for the needs of the applications outside diagnostic applications. At its core, this company looks into the aspect of upgrading patient care along with productivity for the operating teams by delivering secure yet impactful AI agents. Hippocratic AI is striving for a respite from many routine matters of a health care system from the perspectives of healthcare service providers so they have more focus time on providing direct care services.

Read also : Apheris, a Berlin-based startup has raised €8.7M funding

Details of the Series B Funding Round

The recent Series B funding round, which was concluded in January 2025, is being led by Kleiner Perkins, one of the major venture capital firms known for having invested in industry giants such as Google and Amazon. The company had further let in existing investors, which include the participation of SV Angel, Premji, General Catalyst, Andreessen Horowitz (a16z), NVIDIA, Universal Health Services, and WellSpan Health. This funding infuses a total of $278 million for Hippocratic AI in its growth trajectory.

Strategic Goals and Expansion Strategy

With the new capital, Hippocratic AI will:

• Expand into New Markets: The company will enter sectors like pharmaceuticals and payer spaces, thereby expanding the scope of its AI solutions.
• Geographic Expansion: Hippocratic AI will expand its operations into regions such as Europe, the Middle East, Africa (EMEA), Latin America (LatAm), and Southeast Asia, thus establishing a global footprint.
• Improve Technological Offerings: The funds will be partly used to enhance the capability of AI across the company. This will ensure that the solutions delivered are both safe and effective as the needs of the healthcare industry continue to evolve.

Read also: Decart AI Secures $32M funding valuation to over $500M

Launch of the AI Agent App Store

As part of the funding announcement, Hippocratic AI has launched its AI Agent App Store. Through this program, clinicians can work directly with the company in developing AI agents specific to patient conditions and operating workflows. Co-development processes are also optimized and short-term; clinicians can create and safely test AI agents within 30 minutes. 

As a result of this project, healthcare professionals can be more involved in developing AI solutions for improving patient care and operational efficiency. 

Healthcare Industry Consequences

Successfully obtaining its initial funding round with the launch of the AI Agent App Store would mark a salient point towards the integration of AI in health care. Further, Hippocratic AI ensures through clinician’s involvement in solution development that developed solutions are neither only technologically advanced nor useless but practically implementable and realistic to the conditions of the everyday healthcare provider environment.

Future Developments

As Hippocratic AI expands its market influence and technology, it will likely have a significant impact on the medical delivery transformation. Company pillars include safety, collaboration with clinicians, and growth into new markets, which places the company at the forefront of healthcare landscape AI.

Summary

Hippocratic AI’s recent milestones mark a deeper trend in using AI in healthcare, as the firm has significant financing and a commitment to collaboration with physicians to develop products that improve the quality of care, operationally optimize things, and bring to bear many of the intricacies of the healthcare system.